A look at Neuralink after FDA trial approval: huge media coverage compared to rivals and worries over hype, but its tech is exciting and potentially miraculous (Ashlee Vance/Bloomberg)

Ashlee Vance / Bloomberg:

A look at Neuralink after FDA trial approval: huge media coverage compared to rivals and worries over hype, but its tech is exciting and potentially miraculous  —  Neuralink has FDA clearance to start messing with people's heads—and not just figuratively.  —  Elon Musk is preparing for the most consequential launch of his career.

bloomberg fda look media media coverage neuralink tech